RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 100 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,585,126 | +9.2% | 69,144 | -21.5% | 0.00% | 0.0% |
| Q2 2023 | $1,452,192 | -81.5% | 88,065 | -80.0% | 0.00% | -80.0% |
| Q1 2023 | $7,848,797 | -26.3% | 439,955 | +20.4% | 0.01% | -37.5% |
| Q4 2022 | $10,645,136 | -15.2% | 365,561 | -28.6% | 0.01% | -20.0% |
| Q3 2022 | $12,549,000 | +139333.3% | 512,187 | +22503.1% | 0.01% | – |
| Q2 2022 | $9,000 | -82.7% | 2,266 | -50.0% | 0.00% | – |
| Q1 2022 | $52,000 | -94.6% | 4,532 | -95.3% | 0.00% | -100.0% |
| Q4 2021 | $958,000 | +22.8% | 96,017 | +60.8% | 0.00% | – |
| Q3 2021 | $780,000 | -69.8% | 59,726 | -54.7% | 0.00% | -100.0% |
| Q2 2021 | $2,583,000 | -20.3% | 131,899 | -13.5% | 0.00% | 0.0% |
| Q1 2021 | $3,242,000 | +1137.4% | 152,428 | +1627.2% | 0.00% | – |
| Q4 2020 | $262,000 | +63.8% | 8,825 | +19.3% | 0.00% | – |
| Q3 2020 | $160,000 | -69.2% | 7,396 | -68.3% | 0.00% | – |
| Q2 2020 | $520,000 | +70.5% | 23,334 | +16.5% | 0.00% | – |
| Q1 2020 | $305,000 | -8.1% | 20,035 | +38.7% | 0.00% | – |
| Q4 2019 | $332,000 | -4.3% | 14,450 | -9.9% | 0.00% | – |
| Q3 2019 | $347,000 | -36.6% | 16,037 | -35.5% | 0.00% | – |
| Q2 2019 | $547,000 | +501.1% | 24,846 | +653.8% | 0.00% | – |
| Q1 2019 | $91,000 | -95.0% | 3,296 | -95.1% | 0.00% | -100.0% |
| Q4 2018 | $1,825,000 | +127.8% | 67,903 | +147.5% | 0.00% | +100.0% |
| Q3 2018 | $801,000 | +1356.4% | 27,434 | +1462.3% | 0.00% | – |
| Q2 2018 | $55,000 | +161.9% | 1,756 | +68.7% | 0.00% | – |
| Q1 2018 | $21,000 | -22.2% | 1,041 | +12.2% | 0.00% | – |
| Q4 2017 | $27,000 | – | 928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |